In 1922, Schultz1 described a series of cases of a peculiar type of necrosing angina accompanied by a marked absolute and especially granulocytic leukopenia. He asserted that these symptoms were manifestations of a specific disease which he called "agranulocytosis." Since that time, numerous reports of similar cases, at present about 125, have appeared in the literature designated as agranulocytosis or agranulocytic angina (Friedemann2). The results of an investigation of 5 cases of agranulocytosis observed between November, 1927, and April, 1928, and a careful and critical study of a large number of records of agranulocytoses induced me to present a discussion of the symptomatology, pathology and differential diagnosis of this disease, because, in my opinion, the term "agranulocytosis" is in a number of cases applied to conditions which differ distinctly from those for which Schultz introduced this name. The following description of the clinical and pathologic aspects of the disease was
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.